These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen]. Bouslama A; Hedhiri H; Marzouki M; Jerray M; Djenayah F Bull Int Union Tuberc; 1985; 60(1-2):29-30. PubMed ID: 4074969 [No Abstract] [Full Text] [Related]
4. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)]. Utkin VV Probl Tuberk; 1978 Oct; (10):23-8. PubMed ID: 714901 [No Abstract] [Full Text] [Related]
5. [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council]. Chaulet P Bull Int Union Tuberc; 1985; 60(1-2):31-3. PubMed ID: 4074970 [No Abstract] [Full Text] [Related]
6. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis]. Zierski M; Bek E Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146 [No Abstract] [Full Text] [Related]
7. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months. Trébucq A; Rieder HL Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189 [No Abstract] [Full Text] [Related]
8. [Our experience in short-course treatment of tuberculosis. Results obtained by using therapeutic regimens of 6 to 8 months]. Ben Kheder A; Chabbou A; Zakhama B; Zaimi M; el Gharbi T; el Mekki L; el Gharbi B Bull Int Union Tuberc; 1985; 60(1-2):26-8. PubMed ID: 4074968 [No Abstract] [Full Text] [Related]
9. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)]. Pretet S; Grosset J; Perdrizet S Bull Int Union Tuberc; 1978 Dec; 53(4):260-1. PubMed ID: 387140 [No Abstract] [Full Text] [Related]
12. [New and future drugs in pulmonary tuberculosis]. Grosset JH; Truffot-Pernot C; Lecoeur H Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():206-10. PubMed ID: 3174565 [No Abstract] [Full Text] [Related]
13. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
14. [Therapy of tuberculosis in the adult]. Schrappe M; Wassermann K; Kroegel C Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936 [No Abstract] [Full Text] [Related]
16. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin]. Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457 [No Abstract] [Full Text] [Related]
17. Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice? Long R; Scalcini M Int J Tuberc Lung Dis; 1999 Sep; 3(9):747-8. PubMed ID: 10488879 [No Abstract] [Full Text] [Related]